Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Indonesia
  Ireland
  Israel
  Italy
  Jamaica
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lichtenstein
  Lithuania
  Luxembourg
  Madagascar
  Malaysia
  Malta
  Mexico
  Montenegro
  Morocco
  Mozambique
  Namibia
  Netherlands
  New Zealand
  Nigeria
  Norway
  Panama
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sri Lanka
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Thailand
  Tunisia
  Turkey
  Uganda
  Ukraine
  United Kingdom
  United States
  Vietnam


   All

Last Update: 06-06-2014  
Related category(ies):
Health & life sciences  |  Success stories

 

Countries involved in the project described in the article:
France  |  Italy  |  Luxembourg  |  Poland  |  United Kingdom
Add to PDF "basket"

DECIDE: enabling earlier diagnosis of dementia

DECIDE stands for 'Diagnostic Enhancement of Confidence by an International Distributed Environment'. This FP7 project brought together 13 partners from five European countries, with the Italian GARR Institute as leading partner. Its aim was to develop and launch an e-service that allows the early diagnosis of Alzheimer's and other neurodegenerative diseases.

Photo of a doctor talking with a patient © Alexander Raths - Fotolia.com

From the end-user perspective, the main advantages of the service developed by DECIDE are its reliability and user-friendliness. The treating physician needs only a computer with a web connection and a standard Internet browser to use the service. This is possible thanks to the so-called grid and cloud computational resources made available by the European Grid Initiative (EGI) and the high-bandwidth network connectivity provided by the European GEANT network, as well as other national research and higher education networks.

Comparing scans to thousands of cases in a matter of minutes

The resources developed by this project fit into the everyday routine of doctors attending to patients affected by Alzheimer’s disease. To give a simple illustration, a neurologist can upload a Magnetic Resonance Imaging (MRI) scan of a patient who is showing signs of mild cognitive impairment. The DECIDE system then compares this scan with thousands of existing images in the system. Less than half an hour later, the neurologist receives a report comparing dozens of indicators of dementia within the scan. The physician is then able to make a more timely and accurate diagnosis than would have been possible without this service. Patients also benefit, as early diagnosis means earlier access to therapy, including more appropriate inclusion in clinical trials.

Principal Investigator Dr Fulvio Galeazzi comments: “DECIDE enables a physician at any remote hospital to analyse an MRI or a Positron Emission Tomography (PET) scan in a few minutes, whereas the same task on a single computer might take weeks or months.”

Alzheimer Europe – connecting science and society

Even though Luxembourg-based Alzheimer Europe did not contribute to the scientific development per se, its equally important role was to communicate the project outcomes to relevant parties in society. It is important to patients with Alzheimer’s disease and to their caregivers and families to learn about new treatment methods in their domain and to have access to this crucial information in a language they can understand. But science communication and the dissemination of research results are also endeavours close to the European policymakers’ hearts.

Thanks to the contribution of project partners such as Alzheimer Europe, a wider non-scientific audience can be reached. Jean Georges, Executive Director of Alzheimer Europe, says: “We are pleased that our participation in FP7 projects has provided a new link between the scientists who seek a better understanding of dementia and the people who live with Alzheimer’s disease and all other forms of dementia.”

DECIDE to set the scene for a wider commercial roll-out

Even though DECIDE ended in March 2013, the service will continue to operate. However, a proven track record is often needed by the medical community before it embraces a new technology such as DECIDE. Therefore, a commercial roll-out would now require a follow-up project. The Italian Ministry of Health has already approved funding for several such follow-up projects involving DECIDE technology. In addition, a group of leading European memory clinics has been approached as potential DECIDE users and the use of the service in other FP7 projects is also being studied.

Alzheimer Europe is also involved in other EU-funded projects in the field of dementia and neurodegenerative diseases, such as NILVAD and PACE, two FP7 projects, PharmaCog, EMIF and AETIONOMY, all funded under the Innovative Medicines Initiative (IMI).

Project details

  • Project acronym: DECIDE
  • Participants: Italy (Coordinator),UK, France, Poland, Luxembourg
  • FP7 Proj. N° 261593
  • Total costs: € 2 986 757
  • EU contribution: € 2 399 998
  • Duration: September 2010 - August 2012

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project web site

Project information on CORDIS

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center